Control of hepatic fatty acid oxidation by 5'-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism.
about
The trifunctional protein mediates thyroid hormone receptor-dependent stimulation of mitochondria metabolismAcetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate dietsMitochondrial fatty acid oxidation in obesityEvidence that the AMP-activated protein kinase stimulates rat liver carnitine palmitoyltransferase I by phosphorylating cytoskeletal componentsAMP-activated protein kinase: the energy charge hypothesis revisited.Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase.Anti-diabetic effect of purple corn extract on C57BL/KsJ db/db mice.Beneficial effects of metformin on energy metabolism and visceral fat volume through a possible mechanism of fatty acid oxidation in human subjects and rats.Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase.Combination of deep sea water and Sesamum indicum leaf extract prevents high-fat diet-induced obesity through AMPK activation in visceral adipose tissueThe effect of 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) on fatty acid oxidation in hepatocytes isolated from neonatal pigletsAntiaging Gene Klotho Deficiency Promoted High-Fat Diet-Induced Arterial Stiffening via Inactivation of AMP-Activated Protein KinaseAMP-activated protein kinase: Role in metabolism and therapeutic implications.Evidence for AMPK-dependent regulation of exocytosis of lipoproteins in a model liver cell line.AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives.Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations.5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo.Tissue-selective estrogen complexes with bazedoxifene prevent metabolic dysfunction in female mice.Mitochondria: a possible nexus for the regulation of energy homeostasis by the endocannabinoid system?The effect of selective estrogen receptor modulators on type 2 diabetes onset in women: Basic and clinical insights.Effects of stimulation of AMP-activated protein kinase on insulin-like growth factor 1- and epidermal growth factor-dependent extracellular signal-regulated kinase pathway.AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge.Methotrexate and erythro-9-(2-hydroxynon-3-yl) adenine therapy for rat adjuvant arthritis and the effect of methotrexate on in vivo purine metabolism.The hypotensive effect of acute and chronic AMP-activated protein kinase activation in normal and hyperlipidemic mice.AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target.5-aminoimidazole-4-carboxamide riboside (AICAR) enhances GLUT2-dependent jejunal glucose transport: a possible role for AMPK.Dan-gua fang improves glycolipid metabolic disorders by promoting hepatic adenosine 5'-monophosphate activated protein kinase expression in diabetic Goto-Kakizaki rats.Treatment with oligonol, a low-molecular polyphenol derived from lychee fruit, attenuates diabetes-induced hepatic damage through regulation of oxidative stress and lipid metabolism.Dietary supplementation with vitamin E and C attenuates dexamethasone-induced glucose intolerance in rats
P2860
Q24596011-FAE3AA21-70AE-4575-B8E7-3B4431B13398Q24683319-0582BE3D-E1D6-4C8B-A2F2-55C4B6E8AAC1Q26820838-F435567E-348B-4DF4-A7A9-4819A5BD37B3Q28290874-3617F67F-DD55-4540-86D4-A01A2ACA7EC5Q33183179-7EC589FC-A87B-4713-8B03-0192DBC61518Q33965444-2D10BF71-6214-4FAD-87F6-6929841EB966Q35050404-7A3C0ED1-7F50-4E3A-B6F0-B3B9F520FE6CQ36269752-0C2731AC-E679-4808-91C3-32A397646B99Q36301403-77AB7CED-CBE4-4636-962C-3CD1E17CF1FFQ36503263-52CD8621-C360-4FEA-BAF3-E2688E72632CQ36552393-BD44E59F-A1F9-4B6E-9948-200E018D398AQ36576464-32B556B2-6263-4108-B1F8-BDEAB1EAA82EQ36616554-72C088D4-9A47-4C88-BD9D-2BFC00F793E3Q37235258-0D63896D-DBC4-4105-B8C6-74FDFFE58CB6Q37401935-72808DE1-6011-4F8A-B34D-64258218B062Q37531997-15D42721-4978-46BF-84FE-A1BFCADE9041Q37608516-E0F31077-8109-4BBD-8270-45AA718C7AA8Q37636428-5E29D9DD-9AB7-42AF-B43B-2BDCFA4C1456Q38209755-F6AB2090-41E5-4AE5-8AF0-CBF63D18EB80Q39129668-A58BDF36-3A05-48B2-AC4B-598232F40FC8Q40819187-D21D8216-1083-4BAA-877B-162814BF9C7CQ40969960-D5521086-69BA-4BE9-85A0-ABF639F5D2E9Q42109128-940B4125-EFE9-463E-9159-6F7E2C2139EDQ42137439-3EB4581D-DA22-4889-811F-565C83171B30Q42468549-9828BE3F-AF1B-4AC4-B9AD-9F6717E3AFF8Q42813833-5EB33CDA-5474-4479-81B0-B5E6AF1DD698Q51317678-CAE4B406-EE0B-4CFC-A21A-69BB048B5CF8Q53429977-207028F9-93BD-4541-BC88-8C88F982AFC3Q57713559-D681203F-342D-440B-82D2-DF7CCD095ABD
P2860
Control of hepatic fatty acid oxidation by 5'-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Control of hepatic fatty acid ...... nyl-CoA-independent mechanism.
@en
Control of hepatic fatty acid ...... nyl-CoA-independent mechanism.
@nl
type
label
Control of hepatic fatty acid ...... nyl-CoA-independent mechanism.
@en
Control of hepatic fatty acid ...... nyl-CoA-independent mechanism.
@nl
prefLabel
Control of hepatic fatty acid ...... nyl-CoA-independent mechanism.
@en
Control of hepatic fatty acid ...... nyl-CoA-independent mechanism.
@nl
P356
P1476
Control of hepatic fatty acid ...... nyl-CoA-independent mechanism.
@en
P2093
P304
P356
10.1006/ABBI.1996.9784
P407
P577
1997-01-01T00:00:00Z